Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Rodriguez-Meira

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Molecular Cell|May 11, 2020
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific TargetsBethan Psaila, Guanlin Wang, Alba Rodriguez-Meira, et al.
Nature Communications|September 28, 2023
Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent mannerTiago C Luis, Nikolaos Barkas, Joana Carrelha, et al.
The Journal of Experimental Medicine|January 8, 2021
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemiaEleni Louka, Benjamin Povinelli, Alba Rodriguez-Meira, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Nature Genetics|September 4, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolutionAlba Rodriguez-Meira, Ruggiero Norfo, Sean Wen, et al.
Nature Communications|November 24, 2023
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysisZijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, et al.
Nature Genetics|June 9, 2025
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1ACharlotte K Brierley, Bon Ham Yip, Giulia Orlando, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Molecular Cell|May 11, 2020
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific TargetsBethan Psaila, Guanlin Wang, Alba Rodriguez-Meira, et al.
Nature Communications|September 28, 2023
Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent mannerTiago C Luis, Nikolaos Barkas, Joana Carrelha, et al.
The Journal of Experimental Medicine|January 8, 2021
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemiaEleni Louka, Benjamin Povinelli, Alba Rodriguez-Meira, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Nature Genetics|September 4, 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolutionAlba Rodriguez-Meira, Ruggiero Norfo, Sean Wen, et al.
Nature Communications|November 24, 2023
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysisZijian Fang, Giuditta Corbizi Fattori, Thomas McKerrell, et al.
Nature Genetics|June 9, 2025
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1ACharlotte K Brierley, Bon Ham Yip, Giulia Orlando, et al.
Pageof 2